WO2019000067A1 - Skin tone-correcting cosmetic composition, use of a cosmetic composition and method for correcting the skin tone in an urban environment - Google Patents

Skin tone-correcting cosmetic composition, use of a cosmetic composition and method for correcting the skin tone in an urban environment Download PDF

Info

Publication number
WO2019000067A1
WO2019000067A1 PCT/BR2018/050215 BR2018050215W WO2019000067A1 WO 2019000067 A1 WO2019000067 A1 WO 2019000067A1 BR 2018050215 W BR2018050215 W BR 2018050215W WO 2019000067 A1 WO2019000067 A1 WO 2019000067A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
extract
composition according
skin tone
cosmetic composition
Prior art date
Application number
PCT/BR2018/050215
Other languages
French (fr)
Portuguese (pt)
Inventor
Patricia DONIZETI GERALDINI
Viviane POLDOUF QUEIJA
Original Assignee
Natura Cosméticos S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natura Cosméticos S.A. filed Critical Natura Cosméticos S.A.
Publication of WO2019000067A1 publication Critical patent/WO2019000067A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • COSMETIC COMPOSITION OF SKIN TISSUE CORRECTION USE OF A COSMETIC COMPOSITION AND METHOD OF CORRECTION OF SKIN TISSUE IN THE URBAN ENVIRONMENT.
  • the present invention relates to cosmetic skin tone correction compositions comprising an antioxidant complex and conditioning agent (s), in the form of a Color Control Cream (or "Color Control Cream” CC Cream "), with an urban approach, which provides effects of cellular detoxification, cellular oxygenation, antioxidant, anti-pollution, anti-stress and barrier fortification, particularly through the mechanisms of AhR, HIF-1a and LC3.
  • an antioxidant complex and conditioning agent s
  • an urban approach which provides effects of cellular detoxification, cellular oxygenation, antioxidant, anti-pollution, anti-stress and barrier fortification, particularly through the mechanisms of AhR, HIF-1a and LC3.
  • Cosmetic compositions have been widely researched and assembled a number of products with diverse and specific purposes within the beautification process.
  • “Color Control Cream” or “CC Cream” are multifunctional products, aimed at neutralizing possible imperfections related to skin tone, such as pallor, redness, opacity and well-being. as providing additional benefits such as hydration and sun protection. In general, they are able to replace the traditional primer and base, and can even be used alone in a makeup and care process.
  • Exposure to environmental factors, including air pollution, smoking, and ultraviolet radiation are responsible for four skin conditions that leave it in a stress condition and lack of radiance:
  • HyR - Damage receptors
  • Figure 1 shows the in vitro efficacy in the AhR marker, where * : significant result according to Student t test / non-polluted / polluted control (P ⁇ 0.05).
  • Figure 2 shows the in vitro efficacy in the synthesis of LC3, where * : significant result according to Student's t test / normal cells / "autophagy-induced” control (P ⁇ 0.05).
  • Figure 3 shows the in vitro efficacy in the induction of HIF-1a, where * : significant result according to Student's t test / normal / control / aged fibroblasts (P ⁇ 0.05).
  • Figure 5 shows the result of the image analysis based on photographs, evaluated in 20 volunteers, to verify the uniformity of skin tone and reduction of periorbital hyperpigmentation after 15 minutes of application of the product (immediate disguise).
  • the present invention relates to cosmetic skin tone correction compositions
  • an antioxidant complex and conditioning agent in the form of a Color Control Cream (or "Color Control Cream” CC cream "), with an urban approach, which provides effects of cell detoxification, cellular oxygenation, antioxidant, anti-pollution, anti-stress and barrier fortification, particularly through the mechanisms of AhR, HIF-1a and LC3.
  • the antioxidant complex is particularly comprised of tocopheryl acetate, Theobroma Cacao extract and Camellia Sinesis extract.
  • the conditioning agent (s) are (are) selected, in particular from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract or combination thereof.
  • compositions of the prior art offer anti-pollution and skin anti-stress efficacy through the activation of skin receptors causing damage by environmental factors.
  • these compositions act in the skin promoting the cleaning, oxygenation, daily defense against the generation of free radicals and removing the impurities resulting from the daily aggressions, forming a barrier that protects the skin from the damages caused by the aggressions of the environment. It is observed a detox / purification action of the skin, as well as fortification, which increases its resistance.
  • compositions according to the present invention are intended to achieve a perfect-looking skin, by removing the natural tone of the skin, leaving the tired, greyish and stained appearance to give rise to radiant skin and naturally perfect.
  • This benefit is achieved by the use of reflective particles and pigments that uniform the skin tone, correcting imperfections, ensuring complete correction. The result is healthy, naturally radiant skin.
  • the application of the compositions according to the present invention provides immediate and 24 hour hydration and protection against UVB / UVA rays.
  • the developed cosmetic form In addition to bringing the innovative texture of ultralight facial oil suitable for the skin, the developed cosmetic form, through a lipidization process, enhances the sensory properties, leaving the skin immediately soft and velvety.
  • the present invention relates to the novel cosmetic skin tone correction composition
  • the novel cosmetic skin tone correction composition comprising:
  • antioxidant complex consisting of tocopheryl acetate, Theobroma Cacao extract and Camellia Sinesis extract;
  • conditioning agent selected from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract, or a combination thereof, particularly about 0.1% a about 5% hydrolyzed extract of Candida Saitoana, about 0.1% to about 5% hydrolyzed rice protein and about 0.1% to about 10% Tropaeolum Majus extract, more particularly about 2% % hydrolyzed extract of Candida Saitoana, about 1.5% of hydrolyzed rice protein and about 3% of Tropaeolum Majus extract; and c) cosmetically acceptable excipients.
  • conditioning agent selected from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract, or a combination thereof, particularly about 0.1% a about 5% hydrolyzed extract of Candida Saitoana, about 0.1% to about 5% hydrolyzed rice protein and about 0.1% to about 10% Tropaeolum Majus extract, more particularly about 2% % hydrolyzed extract
  • compositions according to the present invention comprise from about 0.1% to about 5% reflecting particles and pigments, for example, sensory modifying particles and optical diffusers selected from polymethylsilsesquioxane, silica and / or boron nitride and / or about 0.1% to about 5% selected pearlescent particles of titanium dioxide, mica, iron oxide and / or tin oxide and / or about 0.1% to about 10% of sunscreen selected from ethylhexylmethoxycinnamate, diethylaminohydroxybenzoylhexyl benzoate, methylene bis-benzotriazolyl tetramethylbutylphenol, bis-ethylhexyloxyphenol methoxyphenyl triazine, titanium dioxide and / or silica.
  • sensory modifying particles and optical diffusers selected from polymethylsilsesquioxane, silica and / or boron nitride and / or about 0.1% to about 5% selected pearlescent particles of titanium dioxide
  • Cosmetically acceptable excipients (c) include, without limitation, those known in the art, e.g. emulsifiers, fragrances, pH adjusters, antioxidants of the formulation, chelating agents and / or preservatives.
  • cosmetically acceptable excipients comprise triacontanyl polyvinyl pyrrolidone (PVP), isoamyl cocoate, dimethicone, caprylyl methacone, dicaprylyl carbonate, murumuru butter, polyglyceryl-10 pentastearate / behenyl alcohol / sodium stearoyl lactylate, glyceryl stearate / PEG-100 stearate, tribehenin / glyceryl behenate / dibehenate, CI77491 / red iron oxide, CI77492 / yellow iron oxide, CI77499 / black iron oxide, CI77891 / titanium dioxide, xanthan gum, triglyceride (VP) copolymer / trilau-reth-4 phosphate / polyglyceryl-2-sesquiisostearate, glycerol, triethanolamine, BHT, disodium EDTA
  • PVP polyvinyl
  • the present invention contemplates the use of the cosmetic composition in the manufacture of a skin tone correction cream for performance in the AhR, HIF-1a and LC3 mechanisms, as well as in the manufacture of a correction cream of skin tone with simultaneous effects of cellular detoxification, cellular oxygenation, antioxidant, antipollution and skin barrier fortification, urban approach.
  • the present invention contemplates an urban skin tone correction method which comprises applying to the skin a cosmetic composition in accordance with the present invention.
  • Example 1 Composition according to the present invention - preferred embodiment
  • the test was performed by Western blotting.
  • the present invention significantly acted on the synthesis of LC3, a specific marker of autophagosomes, in 38%.
  • the autophagic activity of the initially titrated cells was increased by moderate dose of H202.
  • Cells normal human fibroblasts, aged human fibroblasts obtained by successive transfers.
  • HIF-1a is significantly reduced by 44% in aged human fibroblasts compared to normal human fibroblasts.
  • the present invention significantly restored the induction of HIF-1 to aged fibroblasts by 63% compared to normal human fibroblasts.
  • This benefit was evaluated by means of a noninvasive objective methodology called corneometry, which evaluates the amount of water added to the surface of the skin with the use of the product through the evaluation of the electrical conductivity of the skin surface.
  • corneometry evaluates the amount of water added to the surface of the skin with the use of the product through the evaluation of the electrical conductivity of the skin surface.
  • measurements were made before application of the product to obtain information about the initial state of the skin, and after 15 minutes, 2 hours, 4 hours, 8 hours, and 24 hours of application of the product to identify the improvement of hydration product provides the skin, both immediately after use, and throughout the day.
  • the applications are made in the region of the forearm, which are regions that present smaller interferences of external factors and are more protected of the solar expositions.
  • composition of the present invention showed moisturizing performance within 24 hours after application thereof.
  • TEWL Transepidermal Water Loss
  • the applications were made in the forearm region, which are regions that have less interference from external factors and are more protected from solar exposures. Significantly positive effects of barrier fortification were obtained at all evaluated times.
  • the percentage of barrier fortification afforded by the product of the invention when compared to the initial state of the skin is as follows:
  • the investigational product applied on the skin of the volar forearm, gave a significant effect of fortification of the skin barrier after 28 days of home use, when compared to the control (skin without application of any products ).
  • the percentage value obtained from fortification of the skin barrier was 13.5% after 28 days of home use, in relation to the initial skin condition and control. 76.9% of the research participants presented fortification of the cutaneous barrier after home use of the research product.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to skin tone-correcting cosmetic compositions, comprising an antioxidant complex and conditioning agent(s), in the form of a skin tone-correcting cream (or "colour control cream" or "CC cream"), for use in an urban environment, which provides cell detoxification, cell oxygenation, antioxidant, antipollution and barrier-strengthening effects, particularly by acting on AhR, HIF-1α and LC3 mechanisms.

Description

"COMPOSIÇÃO COSMÉTICA DE CORREÇÃO DE TOM DE PELE, USO DE UMA COMPOSIÇÃO COSMÉTICA E MÉTODO DE CORREÇÃO DE TOM DE PELE EM AMBIENTE URBANO".  "COSMETIC COMPOSITION OF SKIN TISSUE CORRECTION, USE OF A COSMETIC COMPOSITION AND METHOD OF CORRECTION OF SKIN TISSUE IN THE URBAN ENVIRONMENT".
Campo da invenção  Field of the Invention
[001 ] A presente invenção trata de composições cosméticas de correção de tom de pele compreendendo um complexo antioxidante e agente(s) condicionante(s), na forma de um creme de correção de tom de pele (ou "Color Control Cream" ou "CC Cream"), com abordagem urbana, que proporciona efeitos de detoxificação celular, oxigenação celular, antioxidante, antipoluição, antiestresse e fortificação de barreira, particularmente pela atuação nos mecanismos de AhR, HIF-1 a e LC3. The present invention relates to cosmetic skin tone correction compositions comprising an antioxidant complex and conditioning agent (s), in the form of a Color Control Cream (or "Color Control Cream" CC Cream "), with an urban approach, which provides effects of cellular detoxification, cellular oxygenation, antioxidant, anti-pollution, anti-stress and barrier fortification, particularly through the mechanisms of AhR, HIF-1a and LC3.
Fundamentos da invenção  Fundamentals of the invention
[002] Composições cosméticas têm sido amplamente pesquisa- das e reúnem um número de produtos com finalidades diversas e específicas dentro do processo de embelezamento.  Cosmetic compositions have been widely researched and assembled a number of products with diverse and specific purposes within the beautification process.
[003] Numa abordagem mais moderna desse seguimento, têm sido desenvolvidos produtos multifuncionais, que se apresentam na forma de cremes e são capazes de promover diversos efeitos cosméti- cos. In a more modern approach of this follow-up, multifunctional products have been developed which are in the form of creams and are capable of promoting various cosmetic effects.
[004] Especificamente, os cremes de correção de tom de pele (no inglês "Color Control Cream" ou "CC Cream") são produtos multifuncionais, voltados a neutralizar possíveis imperfeições relacionadas ao tom da pele, como palidez, vermelhidão, opacidade, bem como pro- porcionar benefícios adicionais, como hidratação e proteção solar. Em geral, são capazes de substituir os tradicionais primer e base, podendo até ser usados sozinhos em um processo de maquiagem e cuidado.  [004] Specifically, "Color Control Cream" or "CC Cream" are multifunctional products, aimed at neutralizing possible imperfections related to skin tone, such as pallor, redness, opacity and well-being. as providing additional benefits such as hydration and sun protection. In general, they are able to replace the traditional primer and base, and can even be used alone in a makeup and care process.
[005] O meio ambiente e nosso estilo de vida influenciam nossa saúde e também a qualidade da nossa pele. Ao longo do dia nossa pele fica exposta a diversos tipos de agente agressores, com a poluição própria de ambientes urbanos, que desequilibram a pele e aceleram o envelhecimento. [006] O envelhecimento, cronológico ou intrínseco, é um desgaste fisiológico que vai ocorrendo em nosso corpo com o passar dos anos de forma natural. Entretanto, a pele está sujeita ao processo de envelhecimento prematuro induzido por fatores ambientais, o qual é denominado envelhecimento extrínseco e pode ser distinguido do envelhecimento cronológico por sinais característicos de cada tipo de envelhecimento. [005] The environment and our lifestyle influence our health and also the quality of our skin. Throughout the day our skin is exposed to several types of aggressive agent, with the pollution of urban environments, which unbalance the skin and accelerate aging. [006] Aging, chronological or intrinsic, is a physiological wear that is occurring in our body over the years in a natural way. However, the skin is subject to the process of premature aging induced by environmental factors, which is termed extrinsic aging and can be distinguished from chronological aging by signs characteristic of each type of aging.
[007] Estudos recentes aumentaram ainda o conhecimento sobre mecanismos moleculares de como fatores ambientais podem contribuir para o envelhecimento extrínseco de pele.  [007] Recent studies have further increased knowledge about molecular mechanisms of how environmental factors may contribute to the extrinsic aging of skin.
[008] A exposição a fatores ambientais, incluindo a poluição do ar, tabagismo e radiação ultravioleta são responsáveis por quatro ma- crodanos na pele, que a deixam em uma condição de estresse e falta de radiância:  Exposure to environmental factors, including air pollution, smoking, and ultraviolet radiation are responsible for four skin conditions that leave it in a stress condition and lack of radiance:
- Receptores causadores de danos (AhR) são ativados e iniciam o processo de quebra de fibras de colágeno e elastina, favorecendo a perda de elasticidade e firmeza da pele, além de desordens da pigmentação da pele. - Damage receptors (AhR) are activated and begin the process of breaking collagen and elastin fibers, favoring the loss of elasticity and firmness of the skin, as well as skin pigmentation disorders.
- A deficiência do fornecimento de oxigénio às células deixa a pele com aparência opaca e sem viço.  - The deficiency of the oxygen supply to the cells leaves the skin looking opaque and without air.
- A redução da qualidade da barreira cutânea, pela oxidação de componentes essenciais e ressecamento da pele, reduz a defesa natural, deixando a pele opaca, áspera e sem vida.  - Reducing the quality of the skin barrier, by oxidizing essential components and drying the skin, reduces the natural defense, leaving the skin opaque, rough and lifeless.
- Geração de radicais livres, que causam a perda de funcionalidade de componentes da pele, oxidando proteínas, lipídeos e bases de DNA da pele.  - Generation of free radicals, which cause loss of functionality of skin components, oxidizing proteins, lipids and DNA bases of the skin.
[009] Esses principais desequilíbrios, causados pelas agressões externas, que aceleram o processo de envelhecimento e deixam a pele estressada, estão particularmente presentes em ambientes urbanos.  [009] These major imbalances, caused by external aggressions, which accelerate the aging process and leave the skin stressed, are particularly present in urban environments.
[0010] Portanto existe a necessidade de composições cosméticas multifuncionais, particularmente voltadas ao ambiente urbano, que se- jam eficientes na correção de tom de pele e também promovam benefícios complementares. Therefore, there is a need for multifunctional cosmetic compositions, particularly directed to the urban environment, which inhibitors in skin tone correction and also promote complementary benefits.
Breve descrição das figuras Brief description of the figures
[001 1 ] A figura 1 apresenta a eficácia in vitro no marcador AhR, onde *: resultado significante de acordo com teste t de Student / controle sem poluição/poluído (P < 0,05). Figure 1 shows the in vitro efficacy in the AhR marker, where * : significant result according to Student t test / non-polluted / polluted control (P <0.05).
[0012] A figura 2 apresenta a eficácia in vitro na síntese de LC3, onde *: resultado significante de acordo com teste t de Student / células normais/ controle de "autofagia induzida" (P < 0,05). Figure 2 shows the in vitro efficacy in the synthesis of LC3, where * : significant result according to Student's t test / normal cells / "autophagy-induced" control (P <0.05).
[0013] A figura 3 apresenta a eficácia in vitro na indução de HIF- 1 a, onde *: resultado significante de acordo com teste t de Student / fibroblastos normais - controle/ envelhecidos (P < 0,05). Figure 3 shows the in vitro efficacy in the induction of HIF-1a, where * : significant result according to Student's t test / normal / control / aged fibroblasts (P <0.05).
[0014] A figura 4 mostra as médias da variação na perda transepi- dermal de água da pele obtidas no início do estudo e após 14 e 28 di- as de uso do produto investigacional, em relação ao controle (Média ± SD, n= 26), onde a primeira coluna apresenta os resultados do controle e a segunda coluna os resultados da presente invenção. Figure 4 shows the means of variation in the transepimeral loss of skin water obtained at the beginning of the study and after 14 and 28 days of use of the investigational product in relation to the control (Mean ± SD, n = 26), wherein the first column shows the control results and the second column the results of the present invention.
[0015] A figura 5 mostra o resultado da análise de imagens baseada em fotografias, avaliadas em 20 voluntárias, para verificação da uniformidade da tonalidade da pele e redução de hiperpigmentação periorbital após 15 minutos da aplicação do produto (disfarce imediato). Figure 5 shows the result of the image analysis based on photographs, evaluated in 20 volunteers, to verify the uniformity of skin tone and reduction of periorbital hyperpigmentation after 15 minutes of application of the product (immediate disguise).
Descrição da invenção  Description of the invention
[0016] A presente invenção trata de composições cosméticas de correção de tom de pele compreendendo um complexo antioxidante e agente(s) condicionante(s), na forma de um creme de correção de tom de pele (ou "Color Control Cream" ou "CC cream"), com abordagem urbana, que proporciona efeitos de detoxificação celular, oxigenação celular, antioxidante, antipoluição, antiestresse e fortificação de barrei- ra, particularmente pela atuação nos mecanismos de AhR, HIF-1 a e LC3. [0017] O complexo antioxidante é particularmente constituído de tocoferil acetato, extrato de Theobroma Cacao e extrato de Camellia Sinesis. The present invention relates to cosmetic skin tone correction compositions comprising an antioxidant complex and conditioning agent (s), in the form of a Color Control Cream (or "Color Control Cream" CC cream "), with an urban approach, which provides effects of cell detoxification, cellular oxygenation, antioxidant, anti-pollution, anti-stress and barrier fortification, particularly through the mechanisms of AhR, HIF-1a and LC3. The antioxidant complex is particularly comprised of tocopheryl acetate, Theobroma Cacao extract and Camellia Sinesis extract.
[0018] O(s) agente(s) condicionante(s) é(são) selecionado(s) parti- cularmente de extrato hidrolisado de Cândida Saitoana, proteína de arroz hidrolisada e/ou extrato de Tropaeolum Majus ou combinação destes.  The conditioning agent (s) are (are) selected, in particular from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract or combination thereof.
[0019] De forma surpreendente em relação às composições do estado da técnica, a combinação de ingredientes desenvolvida oferece eficácia antipoluição e antiestresse da pele por meio da ativação de receptores da pele causadores de danos por fatores ambientais. Como resultado, ditas composições atuam na pele promovendo a limpeza, oxigenação, defesa diária contra a geração de radicais livres e removendo as impurezas decorrentes das agressões cotidianas, formando uma barreira que protege a pele dos danos causados pelas agressões do meio ambiente. Observa-se uma ação de detox/purificação da pele, bem como de fortificação, que aumenta sua resistência.  Surprisingly with respect to compositions of the prior art, the combination of ingredients developed offers anti-pollution and skin anti-stress efficacy through the activation of skin receptors causing damage by environmental factors. As a result, these compositions act in the skin promoting the cleaning, oxygenation, daily defense against the generation of free radicals and removing the impurities resulting from the daily aggressions, forming a barrier that protects the skin from the damages caused by the aggressions of the environment. It is observed a detox / purification action of the skin, as well as fortification, which increases its resistance.
[0020] Além disso, as composições de acordo com a presente invenção destinam-se a alcançar uma pele de aparência perfeita, des- pertando o tom natural da pele, deixando o aspecto cansado, acinzentado e com manchas dar lugar a uma pele radiante e naturalmente perfeita. Esse benefício é alcançado pela utilização de partículas refle- toras e pigmentos que uniformizam o tom da pele, corrigindo imperfeições, garantindo correção completa. O resultado é uma pele saudável e naturalmente radiante. In addition, the compositions according to the present invention are intended to achieve a perfect-looking skin, by removing the natural tone of the skin, leaving the tired, greyish and stained appearance to give rise to radiant skin and naturally perfect. This benefit is achieved by the use of reflective particles and pigments that uniform the skin tone, correcting imperfections, ensuring complete correction. The result is healthy, naturally radiant skin.
[0021 ] Adicionalmente, de forma simultânea, além da proteção contra os danos causados pelas agressões diárias (como radiação solar, poluição, falta de oxigénio, nutrientes e água, que aceleram o envelhecimento e a falta de radiância da pele) e correção do tom da pele, a aplicação das composições de acordo com a presente invenção proporciona hidratação imediata e de 24 horas e proteção contra os raios UVB/UVA. [0022] Além de trazer a textura inovadora de óleo facial ultraleve adequado para a pele, a forma cosmética desenvolvida, por meio de um processo de lipidização, melhora as propriedades sensoriais, deixando a pele imediatamente macia e aveludada. In addition, simultaneously, in addition to protection against damage caused by daily aggressions (such as solar radiation, pollution, lack of oxygen, nutrients and water, which accelerate aging and lack of radiance of the skin) and tone correction of the skin, the application of the compositions according to the present invention provides immediate and 24 hour hydration and protection against UVB / UVA rays. In addition to bringing the innovative texture of ultralight facial oil suitable for the skin, the developed cosmetic form, through a lipidization process, enhances the sensory properties, leaving the skin immediately soft and velvety.
[0023] Assim, a presente invenção diz respeito à nova composição cosmética de correção de tom de pele que compreende: Thus, the present invention relates to the novel cosmetic skin tone correction composition comprising:
a) cerca de 0,001 % a cerca de 2% em peso, particularmente cerca de 0,3% em peso de complexo antioxidante constituído de tocoferil acetato, extrato de Theobroma Cacao e extrato de Camellia Sinesis;  a) from about 0.001% to about 2% by weight, particularly about 0.3% by weight of antioxidant complex consisting of tocopheryl acetate, Theobroma Cacao extract and Camellia Sinesis extract;
b) cerca de 0,1 % a cerca de 10% em peso de agente condicionante selecionado de extrato hidrolisado de Cândida Saitoana, proteína de arroz hidrolisada e/ou extrato de Tropaeolum Majus, ou combinação destes, particularmente cerca de 0,1 % a cerca de 5% de extrato hidrolisado de Cândida Saitoana, cerca de 0,1 % a cerca de 5% de proteína de arroz hidrolisada e cerca de 0,1 % a cerca de 10% de extrato de Tropaeolum Majus, mais particularmente cerca de 2% de extrato hidrolisado de Cândida Saitoana, cerca de 1 ,5% de proteína de arroz hidrolisada e cerca de 3% de extrato de Tropaeolum Majus; e c) excipientes cosmeticamente aceitáveis.  b) about 0.1% to about 10% by weight of conditioning agent selected from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract, or a combination thereof, particularly about 0.1% a about 5% hydrolyzed extract of Candida Saitoana, about 0.1% to about 5% hydrolyzed rice protein and about 0.1% to about 10% Tropaeolum Majus extract, more particularly about 2% % hydrolyzed extract of Candida Saitoana, about 1.5% of hydrolyzed rice protein and about 3% of Tropaeolum Majus extract; and c) cosmetically acceptable excipients.
[0024] Adicionalmente, as composições de acordo com a presente invenção compreendem cerca de 0,1 % a cerca de 5% de partículas refletoras e pigmentos, por exemplo, partículas modificadoras de sensorial e difusoras ópticas selecionadas de polimetilsilsesquioxana, síli- ca e/ou nitreto de boro e/ou cerca de 0,1 % a cerca de 5% de partículas perolizadas selecionadas de dióxido de titânio, mica, óxido de ferro e/ou óxido de estanho e/ou cerca de 0,1 % a cerca de 10% de filtro solar selecionado de etil-hexil metoxicinamato, dietilamino hidroxibenzoil hexil benzoato, metileno bis-benzotriazolil tetrametilbutilfenol, bis-etil- hexiloxifenol metoxifenil triazina, dióxido de titânio e/ou sílica.  In addition, the compositions according to the present invention comprise from about 0.1% to about 5% reflecting particles and pigments, for example, sensory modifying particles and optical diffusers selected from polymethylsilsesquioxane, silica and / or boron nitride and / or about 0.1% to about 5% selected pearlescent particles of titanium dioxide, mica, iron oxide and / or tin oxide and / or about 0.1% to about 10% of sunscreen selected from ethylhexylmethoxycinnamate, diethylaminohydroxybenzoylhexyl benzoate, methylene bis-benzotriazolyl tetramethylbutylphenol, bis-ethylhexyloxyphenol methoxyphenyl triazine, titanium dioxide and / or silica.
[0025] Os excipientes cosmeticamente aceitáveis (c) incluem, sem qualquer limitação, aqueles conhecidos no estado da técnica, por exemplo, formadores de filme, condicionantes, emolientes, colorantes, agentes de viscosidade/suspensão, umectantes, fragrâncias, ajustadores de pH, antioxidantes da formulação, agentes quelantes e/ou conservantes. Cosmetically acceptable excipients (c) include, without limitation, those known in the art, e.g. emulsifiers, fragrances, pH adjusters, antioxidants of the formulation, chelating agents and / or preservatives.
[0026] De maneira preferencial, mas não limitativa, os excipientes cosmeticamente aceitáveis compreendem triacontanil polivinil pirroli- dona (PVP), isoamil cocoato, dimeticona, caprilil meticona, dicaprilil carbonato, manteiga de murumuru, poligliceril-10 pentaestearato/ behenil álcool/ sódio estearoil lactilato, gliceril estearato/ PEG-100 es- tearato, tribehenin/gliceril behenato/dibehenato, CI77491 /óxido de ferro vermelho, CI77492/óxido de ferro amarelo, CI77499/óxido de ferro preto, CI77891 /dióxido de titânio, goma xantana, triglicerídeo caprílico- cáprico / acriloildimetiltaurato/vinil pirrolidona (VP) copolímero / trilau- reth-4 fosfato /poligliceril-2 sesquiisostearato, glicerina, trietanolamina, BHT, dissódio EDTA, iodopropinil butilcarbamato, fenoxietanol, ou misturas destes. Preferably, but not limiting, cosmetically acceptable excipients comprise triacontanyl polyvinyl pyrrolidone (PVP), isoamyl cocoate, dimethicone, caprylyl methacone, dicaprylyl carbonate, murumuru butter, polyglyceryl-10 pentastearate / behenyl alcohol / sodium stearoyl lactylate, glyceryl stearate / PEG-100 stearate, tribehenin / glyceryl behenate / dibehenate, CI77491 / red iron oxide, CI77492 / yellow iron oxide, CI77499 / black iron oxide, CI77891 / titanium dioxide, xanthan gum, triglyceride (VP) copolymer / trilau-reth-4 phosphate / polyglyceryl-2-sesquiisostearate, glycerol, triethanolamine, BHT, disodium EDTA, iodopropynyl butylcarbamate, phenoxyethanol, or mixtures thereof.
[0027] Em uma segunda realização, a presente invenção contempla o uso da composição cosmética na fabricação de um creme de correção de tom de pele para atuação nos mecanismos de AhR, HIF- 1 a e LC3, bem como na fabricação de um creme de correção de tom de pele com efeitos simultâneos de detoxificação celular, de oxigenação celular, antioxidante, antipoluição e fortificação de barreira da pele, de abordagem urbana.  In a second embodiment, the present invention contemplates the use of the cosmetic composition in the manufacture of a skin tone correction cream for performance in the AhR, HIF-1a and LC3 mechanisms, as well as in the manufacture of a correction cream of skin tone with simultaneous effects of cellular detoxification, cellular oxygenation, antioxidant, antipollution and skin barrier fortification, urban approach.
[0028] Em outra realização, a presente invenção contempla um método de correção de tom de pele em ambiente urbano que compreende aplicar na pele uma composição cosmética de acordo com a presente invenção.  In another embodiment, the present invention contemplates an urban skin tone correction method which comprises applying to the skin a cosmetic composition in accordance with the present invention.
[0029] Os exemplos a seguir, sem impor qualquer limitação, ilustram as composições de acordo com a presente invenção, bem como seus efeitos aqui descritos.  The following examples, without any limitation, illustrate the compositions according to the present invention, as well as their effects described herein.
Exemplos Exemplo 1 . Composição de acordo com a presente invenção - realização preferida Examples Example 1. Composition according to the present invention - preferred embodiment
[0030] A tabela a seguir ilustra as composições de acordo com a presente invenção.  The following table illustrates the compositions according to the present invention.
Tabela 1 . Composições cosméticas de maquiagem de efeito mate Table 1. Cosmetic compositions of matte effect makeup
Figure imgf000009_0001
Figure imgf000010_0001
Figure imgf000009_0001
Figure imgf000010_0001
Exemplo 2. Eficácia in vitro nos marcadores  Example 2. In vitro efficacy in the markers
[0031 ] Foi testada in vitro a eficácia nos marcadores: The effectiveness in markers was tested in vitro:
A -"Aryl-hydrocarbon Receptor" (AhR) relativo ao efeito antipoluição; B - HIF1 -a relativo ao efeito de oxigenação; A - "Aryl-hydrocarbon Receptor" (AhR) concerning the anti-pollution effect; B - HIF1 -a relative to the oxygenation effect;
C - Proteína LC3 relativa à detoxificação. C - Detoxification LC3 protein.
[0032] A - Foi determinada a capacidade de limitar a ativação de AhR após exposição de queratinócitos humanos a poluentes ambientais cuja fonte é fumo de cigarro e 0,25 μΜ de emissões de veículos (benzo[a]pireno (BaP)).  A - The ability to limit AhR activation after exposure of human keratinocytes to environmental pollutants whose source is cigarette smoke and 0.25 μΜ vehicle emissions (benzo [a] pyrene (BaP)) has been determined.
[0033] O teste foi realizado por Western blot. The test was performed by Western blotting.
[0034] Os resultados são apresentados na figura 1 , onde observa- se translocação nuclear no receptor Ah significante (80%), ou seja, a composição de acordo com a presente invenção significantemente reduz a ativação do receptor Ah. [0035] B - Foi avaliado o efeito da composição de acordo com a presente invenção na síntese de proteína LC3-II (cadeia leve 3-11), um marcador específico autofagossômico. The results are shown in figure 1, where nuclear translocation is observed at the significant Ah receptor (80%), i.e., the composition according to the present invention significantly reduces Ah receptor activation. The effect of the composition according to the present invention on the synthesis of LC3-II protein (light chain 3-11), a specific autophagosomal marker, was evaluated.
[0036] Modelo de queratinócitos "autofagia induzidos": células em que autofagia foi iniciada por uma dose moderada de H202 (250 μΜ - 3 horas).  "Autophagy induced" keratinocytes model: cells in which autophagy was initiated by a moderate dose of H202 (250 μΜ - 3 hours).
[0037] Método de visualização por imunocitologia em queratinócitos HaCat.  [0037] Immunocytology visualization method in HaCat keratinocytes.
[0038] Os resultados são apresentados na figura 2.  The results are shown in figure 2.
[0039] A presente invenção significantemente atuou na síntese de LC3, um marcador específico de autofagossomos, em 38%. The present invention significantly acted on the synthesis of LC3, a specific marker of autophagosomes, in 38%.
[0040] Foi aumentada a atividade autofágica das células inicialmente tituladas por dose moderada de H202. The autophagic activity of the initially titrated cells was increased by moderate dose of H202.
[0041 ] C- Foi avaliado, em fibroblastos humanos normais e enve- lhecidos, o efeito da presente invenção na indução de HIF-1 a, um fator induzido por hipoxia e que chave reguladora da resposta celular a falta de oxigénio.  In normal and aged human fibroblasts, the effect of the present invention was evaluated on the induction of HIF-1a, a hypoxia-induced factor and a key to regulate the cellular response of the lack of oxygen.
[0042] Modelo de células em condições de hipoxia induzida por 50 μΜ de cobalto(Co).  [0042] Cell model under conditions of hypoxia induced by 50 μΜ cobalt (Co).
[0043] Células: fibroblastos humanos normais, fibroblastos humanos envelhecidos obtidos por sucessivas transferências. [0043] Cells: normal human fibroblasts, aged human fibroblasts obtained by successive transfers.
[0044] Método: Western blot. Method: Western blot.
[0045] Os resultados são apresentados na figura 3. The results are shown in figure 3.
[0046] Em condições de hipoxia, a indução de HIF-1 a é significan- temente reduzida em 44% em fibroblastos humanos envelhecidos comparados a fibroblastos humanos normais. Under conditions of hypoxia, the induction of HIF-1a is significantly reduced by 44% in aged human fibroblasts compared to normal human fibroblasts.
[0047] A presente invenção significantemente restaurou a indução de HIF-1 a dos fibroblastos envelhecidos em 63% comparado aos fibroblastos humanos normais.  The present invention significantly restored the induction of HIF-1 to aged fibroblasts by 63% compared to normal human fibroblasts.
Exemplo 3. Hidratação Example 3. Hydration
[0048] Esse benefício foi avaliado por meio de uma metodologia objetiva não invasiva chamada corneometria, que avalia a quantidade de água agregada à superfície da pele com o uso do produto através da avaliação da condutância elétrica da superfície da pele. Nesta avaliação foram feitas medidas antes da aplicação do produto, para ter informações sobre o estado inicial da pele, e após 15 minutos, 2 horas, 4 horas, 8 horas, e 24 horas da aplicação do mesmo para identificar a melhora da hidratação que o produto proporciona à pele, tanto imediatamente após o seu uso, como ao longo do dia. As aplicações são feitas na região do antebraço, que são regiões que apresentam menores interferências de fatores externos e se mostram mais protegidas das exposições solares. [0048] This benefit was evaluated by means of a noninvasive objective methodology called corneometry, which evaluates the amount of water added to the surface of the skin with the use of the product through the evaluation of the electrical conductivity of the skin surface. In this evaluation, measurements were made before application of the product to obtain information about the initial state of the skin, and after 15 minutes, 2 hours, 4 hours, 8 hours, and 24 hours of application of the product to identify the improvement of hydration product provides the skin, both immediately after use, and throughout the day. The applications are made in the region of the forearm, which are regions that present smaller interferences of external factors and are more protected of the solar expositions.
[0049] Como resultado, reconhece-se que a composição da presente invenção apresentou performance hidratante em até 24 horas após aplicação do mesmo.  As a result, it is recognized that the composition of the present invention showed moisturizing performance within 24 hours after application thereof.
Exemplo 4. Fortificação de Barreira Example 4. Barrier Fortification
[0050] Este benefício foi avaliado por meio de uma metodologia objetiva não invasiva chamada TEWL (Transepidermal Water Loss), que indica a integridade da barreira cutânea por meio das medidas de perda de água transdérmica, que traduz uma das funções primordiais da barreira que é, além de prevenir a entrada de microrganismos, substâncias químicas e várias formas de radiação, impedir a perda de água e nutrientes do organismo mantendo a impermeabilidade da pele, essencial para o bom funcionamento do organismo. Nesta avaliação foram feitas medidas antes da aplicação do produto, para ter informações sobre o estado inicial da pele, e após 14 e 28 dias de uso domiciliar do mesmo. [0050] This benefit was evaluated by means of a non-invasive objective methodology called TEWL (Transepidermal Water Loss), which indicates the integrity of the cutaneous barrier by means of transdermal water loss measurements, which translates into one of the primordial functions of the barrier that is , in addition to preventing the entry of microorganisms, chemical substances and various forms of radiation, prevent the loss of water and nutrients of the body while maintaining impermeability of the skin, essential for the proper functioning of the body. In this evaluation, measurements were taken before the application of the product, to obtain information about the initial state of the skin, and after 14 and 28 days of home use.
[0051 ] As aplicações foram feitas na região do antebraço, que são regiões que apresentam menos interferências de fatores externos e se mostram mais protegidas das exposições solares. Obtiveram-se efeitos significativamente positivos de fortificação de barreira em todos os tempos avaliados.  The applications were made in the forearm region, which are regions that have less interference from external factors and are more protected from solar exposures. Significantly positive effects of barrier fortification were obtained at all evaluated times.
[0052] A porcentagem de fortificação de barreira oferecida pelo produto da invenção quando comparado ao estado inicial da pele (an- tes da aplicação do mesmo), bem como a porcentagem de voluntários em que este efeito foi observado em 28 dias de uso é como segue:The percentage of barrier fortification afforded by the product of the invention when compared to the initial state of the skin (an- and the percentage of volunteers in which this effect was observed in 28 days of use is as follows:
- % de melhora: 13,5 -% improvement: 13.5
- % de voluntários que apresentaram melhora: 76,9  -% of volunteers who showed improvement: 76.9
[0053] A figura 4 mostra as médias da variação na perda transepi- dermal de água da pele obtidas no início do estudo e após 14 e 28 dias de uso do produto investigacional, em relação ao controle (Média ± SD, n= 26). Figure 4 shows the means of variation in the transepimeral loss of skin water obtained at the beginning of the study and after 14 and 28 days of use of the investigational product in relation to the control (Mean ± SD, n = 26) .
[0054] De acordo com os resultados obtidos, o produto investiga- cional, aplicado sobre a pele do antebraço volar, conferiu efeito significativo de fortificação da barreira cutânea após 28 dias de uso domiciliar, quando comparado ao controle (pele sem aplicação de quaisquer produtos). O valor percentual obtido de fortificação da barreira cutânea foi de 13,5% após 28 dias de uso domiciliar, em relação à condição inicial da pele e ao controle. 76,9% das participantes da pesquisa apresentaram fortificação da barreira cutânea após o uso domiciliar do produto investigacional.  According to the results obtained, the investigational product, applied on the skin of the volar forearm, gave a significant effect of fortification of the skin barrier after 28 days of home use, when compared to the control (skin without application of any products ). The percentage value obtained from fortification of the skin barrier was 13.5% after 28 days of home use, in relation to the initial skin condition and control. 76.9% of the research participants presented fortification of the cutaneous barrier after home use of the research product.
Exemplo 5. Tom de pele Example 5. Skin Tone
[0055] Este benefício foi avaliado através de uma metodologia de avaliação da homogeneidade da cor da pele em regiões faciais (imantar, mentoniana) e de redução da hiperpigmentação periorbital, baseada no método de análise de imagens baseada em fotografias das regiões de interesse. Neste teste foram avaliadas 20 voluntárias, sendo registradas a uniformidade da tonalidade da pele e a redução de hi- perpigmentação periorbital após 15 minutos da aplicação do produto (disfarce imediato) - conforme figura 5.  [0055] This benefit was evaluated through a methodology for assessing the homogeneity of skin color in facial (imantar and mental) regions and reduction of periorbital hyperpigmentation, based on the method of image analysis based on photographs of the regions of interest. In this test, 20 volunteers were evaluated, with uniformity of skin tone and reduction of periorbital hyperpigmentation after 15 minutes of application (immediate disguise) - according to figure 5.
Exemplo 6. Eficácia Percebida Example 6. Perceived Effectiveness
[0056] Este benefício foi avaliado por meio de uma metodologia clínica/ subjetiva, na qual os parâmetros desejados são avaliados pe- las voluntárias que declaram sua opinião sobre a melhora ou não do estado de sua pele. Neste estudo foram feitas avaliações antes da aplicação do produto, para terem informações sobre o estado inicial da pele, e após 15 minutos, 4 e 8 horas do uso do produto. [0056] This benefit was assessed by a clinical / subjective methodology in which the desired parameters are evaluated by volunteers who state their opinion on whether or not their skin condition is improved. In this study, assessments were made before application of the product, to have information about the initial state of the skin, and after 15 minutes, 4 and 8 hours of use of the product.
[0057] A tabela a seguir mostra os resultados, onde é apresentado percentual de participantes que sentiram melhora. [0057] The following table shows the results, which shows the percentage of participants who experienced improvement.
Tabela 2. Eficácia percebida do produto de acordo com a presente in- Table 2. Perceived efficacy of the product according to the present invention
Questões T15 min T4 horas T8 horasQuestions T15 min T4 hours T8 hours
Questão 1 . Em relação à cobertu98,3 — — ra homogénea Question 1. In relation to the homogeneous cover
Questão 2. Em relação ao aca93,3 — — bamento natural  Question 2. Regarding the natural occurrence
Questão 3. Em relação à hidrata93,3 93,3 90,0 ção (maciez e suavidade)  Question 3. Regarding hydration 93.3 90.0 tion (softness and softness)
Questão 4. Em relação à unifor90,0 91 ,7 90,0 midade  Question 4. In relation to the uniform 90,0 91, 7 90,0 midade
Questão 5. Aparência saudável 88,3 90,0 90,0 Question 5. Healthy appearance 88.3 90.0 90.0
Questão 6. Em relação à lumino86,7 88,3 88,3 sidade e à radiância Question 6. Regarding lumino86.7 88.3 88.3 sity and radiance
Questão 7. Em relação à melhora 86,7 86,7 88,3 da textura  Question 7. Regarding the improvement 86.7 86.7 88.3 of the texture
Questão 8. Em relação ao aspec86,7 86,7 85,0 to matte  Question 8. Regarding the aspect86,7 86,7 85,0 to matte
Questão 9. Em relação à pele 81 ,7 83,3 83,3 corada, com rubor natural  Question 9. Regarding skin 81, 83.3 83.3 stained, with natural flushing
Questão 10. Em relação à pele 80,0 81 ,7 81 ,7 aveludada, com sensação de  Question 10. In relation to the velvety skin 80.0 81, 7 81, 7, with a
pêssego  peach
Questão 1 1 . Em relação ao dis78,3 80,0 80,0 farce de imperfeições  Question 1 1. In relation to the dis78,3 80,0 80,0 farce of imperfections
Questão 12. Em relação à redu78,3 78,3 80,0 ção dos poros aparentes Questão 13. Em relação à redu73,3 78,3 76,7 ção de linhas finas Question 12. Regarding the reduction78.3 78.3 80.0 tion of the apparent pores Question 13. In relation to the reduction73.3 78.3 76.7 tion of fine lines
Questão 14. Em relação ao dis65,0 71 ,7 75,0 farce das rugas  Question 14. Regarding dis65.0 71, 7 75.0 farce of wrinkles
[0058] O homem da técnica saberá prontamente avaliar, por meio dos ensinamentos contidos no texto e nos exemplos apresentados, vantagens da invenção e propor variações e alternativas equivalentes de realização, sem fugir do escopo da invenção, conforme definido nas reivindicações anexas.  The man skilled in the art will readily appreciate, by the teachings contained in the text and in the examples presented, advantages of the invention and propose variations and equivalent alternatives of attainment without departing from the scope of the invention as defined in the appended claims.

Claims

REIVINDICAÇÕES
1 . COMPOSIÇÃO COSMÉTICA DE CORREÇÃO DE TOM DE PELE caracterizada pelo fato de que compreende:  1 . COSMETIC COMPOSITION OF SKIN TISSUE CORRECTION characterized in that it comprises:
a) complexo antioxidante constituído de tocoferil acetato, extrato de Theobroma Cacao e extrato de Camellia Sinesis; a) antioxidant complex consisting of tocopheryl acetate, extract of Theobroma Cacao and extract of Camellia Sinesis;
b) agente condicionante selecionado de extrato hidrolisado de Cândida Saitoana, proteína de arroz hidrolisada e/ou extrato de Tropaeolum Majus ou combinação destes; b) conditioning agent selected from Candida Saitoana hydrolyzed extract, hydrolyzed rice protein and / or Tropaeolum Majus extract or combination thereof;
c) excipientes cosmeticamente aceitáveis. c) cosmetically acceptable excipients.
2. COMPOSIÇÃO, de acordo com a reivindicação 1 , caracterizada pelo fato de que compreende cerca de 0,001 % a cerca de 2% em peso de complexo antioxidante. A composition according to claim 1, characterized in that it comprises from about 0.001% to about 2% by weight of antioxidant complex.
3. COMPOSIÇÃO, de acordo com a reivindicação 2, caracterizada pelo fato de que compreende cerca de 0,3% em peso de complexo antio- xidante.  A composition according to claim 2, characterized in that it comprises about 0.3% by weight of anti-oxidant complex.
4. COMPOSIÇÃO, de acordo com a reivindicação 1 , caracterizada pelo fato de que compreende cerca de 0,1 % a cerca de 10% em peso de agente condicionante.  A composition according to claim 1, characterized in that it comprises from about 0.1% to about 10% by weight of conditioning agent.
5. COMPOSIÇÃO, de acordo com a reivindicação 4, caracterizada pe- lo fato de que compreende cerca de 0,1 % a cerca de 5% de extrato hidrolisado de Cândida Saitoana, cerca de 0,1 % a cerca de 5% de proteína de arroz hidrolisada e cerca de 0,1 % a cerca de 10% de extrato de Tropaeolum Majus.  The composition according to claim 4, characterized in that it comprises from about 0.1% to about 5% hydrolyzed extract of Candida Saitoana, from about 0.1% to about 5% protein of hydrolyzed rice and about 0.1% to about 10% of Tropaeolum Majus extract.
6. COMPOSIÇÃO, de acordo com a reivindicação 5, caracterizada pe- lo fato de que compreende cerca de 2% de extrato hidrolisado de A composition according to claim 5, characterized in that it comprises about 2% hydrolysed extract of
Cândida Saitoana, cerca de 1 ,5% de proteína de arroz hidrolisada e cerca de 3% de extrato de Tropaeolum Majus. Candida Saitoana, about 1.5% hydrolyzed rice protein and about 3% Tropaeolum Majus extract.
7. COMPOSIÇÃO, de acordo com qualquer uma das reivindicações 1 a 6, caracterizada pelo fato de que compreende adicionalmente cerca de 0,1 % a cerca de 5% de partículas modificadoras de sensorial e difusoras ópticas selecionadas de polimetilsilsesquioxana, sílica e/ou nitreto de boro. A composition according to any one of claims 1 to 6, characterized in that it additionally comprises from about 0.1% to about 5% of sensorial modifying particles and optical diffusers selected from polymethylsilsesquioxane, silica and / or nitride of boron.
8. COMPOSIÇÃO, de acordo com qualquer uma das reivindicações 1 a 6, caracterizada pelo fato de que compreende adicionalmente cerca de 0,1 % a cerca de 5% de partículas perolizadas selecionadas de dióxido de titânio, mica, óxido de ferro e/ou óxido de estanho. A composition according to any one of claims 1 to 6, characterized in that it additionally comprises from about 0.1% to about 5% of pearlescent particles selected from titanium dioxide, mica, iron oxide and / or tin oxide.
9. COMPOSIÇÃO, de acordo com qualquer uma das reivindicações 1 a 6, caracterizada pelo fato de que compreende adicionalmente cerca de 0,1 % a cerca de 10% de filtro solar selecionado de etil-hexil metoxi- cinamato, dietilamino hidroxibenzoil hexil benzoato, metileno bis- benzotriazolil tetrametilbutilfenol, bis-etil-hexiloxifenol metoxifenil triazi- na, dióxido de titânio e/ou sílica. A composition according to any one of claims 1 to 6, characterized in that it additionally comprises from about 0.1% to about 10% of the sunscreen selected from ethylhexylmethoxycinnamate, diethylaminohydroxybenzoylhexyl benzoate, methylene bis-benzotriazolyl tetramethylbutylphenol, bis-ethylhexyloxyphenol methoxyphenyl triazine, titanium dioxide and / or silica.
10. USO DE UMA COMPOSIÇÃO COSMÉTICA, conforme definida em qualquer uma das reivindicações 1 a 9, caracterizado pelo fato de ser na fabricação de um creme de correção de tom de pele para atuação nos mecanismos de AhR, HIF-1 a e LC3.  Use of a COSMETIC COMPOSITION as defined in any one of claims 1 to 9, characterized in that it is in the manufacture of a skin tone correction cream for performance in the AhR, HIF-1α and LC3 mechanisms.
1 1 . USO, de acordo com a reivindicação 10, caracterizado pelo fato de ser na fabricação de um creme de correção de tom de pele com efeitos simultâneos de detoxificação celular, de oxigenação celular, antioxidante, antipoluição e fortificação de barreira da pele. 1 1. The use according to claim 10, characterized in that it is in the manufacture of a skin tone correction cream with simultaneous effects of cellular detoxification, cellular oxygenation, antioxidant, anti-pollution and skin barrier fortification.
12. USO, de acordo com a reivindicação 1 1 , caracterizado pelo fato de ser na fabricação de um creme de correção de tom de pele em ambiente urbano.  A use according to claim 11, characterized in that it is in the manufacture of a skin tone correction cream in an urban environment.
13. MÉTODO DE CORREÇÃO DE TOM DE PELE EM AMBIENTE URBANO caracterizado pelo fato de que compreende aplicar na pele uma composição cosmética conforme definida em qualquer uma das reivindicações 1 a 9.  A method of correcting skin tone in an urban environment characterized in that it comprises applying to the skin a cosmetic composition as defined in any one of claims 1 to 9.
PCT/BR2018/050215 2017-06-30 2018-06-29 Skin tone-correcting cosmetic composition, use of a cosmetic composition and method for correcting the skin tone in an urban environment WO2019000067A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102017014319A BR102017014319A2 (en) 2017-06-30 2017-06-30 skin tone correction cosmetic composition, use of a cosmetic composition and method of skin tone correction in an urban environment
BRBR1020170143198 2017-06-30

Publications (1)

Publication Number Publication Date
WO2019000067A1 true WO2019000067A1 (en) 2019-01-03

Family

ID=64740264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2018/050215 WO2019000067A1 (en) 2017-06-30 2018-06-29 Skin tone-correcting cosmetic composition, use of a cosmetic composition and method for correcting the skin tone in an urban environment

Country Status (3)

Country Link
AR (1) AR112262A1 (en)
BR (1) BR102017014319A2 (en)
WO (1) WO2019000067A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165553A1 (en) 2019-02-13 2020-08-20 Block Container Systems Limited Rig, corner unit

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053415A1 (en) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
FR2965483A1 (en) * 2010-10-04 2012-04-06 Silab Sa COSMETIC USE OF A TROPAEOLUM MAJUS EXTRACT AS AN ACTIVE INGREDIENT TO PROMOTE OXYGENATION OF SKIN TISSUE
WO2014043009A1 (en) * 2012-09-14 2014-03-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
WO2015164657A1 (en) * 2014-04-23 2015-10-29 Bcs Business Consulting Services Pte Ltd Incorporation of water soluble component(s) into anhydrous formulations
JP2016044171A (en) * 2014-08-25 2016-04-04 株式会社 Ito Reserch Novel compound and mixture composition of the same
US9849077B2 (en) * 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053415A1 (en) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
FR2965483A1 (en) * 2010-10-04 2012-04-06 Silab Sa COSMETIC USE OF A TROPAEOLUM MAJUS EXTRACT AS AN ACTIVE INGREDIENT TO PROMOTE OXYGENATION OF SKIN TISSUE
WO2014043009A1 (en) * 2012-09-14 2014-03-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
US9849077B2 (en) * 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions
WO2015164657A1 (en) * 2014-04-23 2015-10-29 Bcs Business Consulting Services Pte Ltd Incorporation of water soluble component(s) into anhydrous formulations
JP2016044171A (en) * 2014-08-25 2016-04-04 株式会社 Ito Reserch Novel compound and mixture composition of the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165553A1 (en) 2019-02-13 2020-08-20 Block Container Systems Limited Rig, corner unit

Also Published As

Publication number Publication date
AR112262A1 (en) 2019-10-09
BR102017014319A2 (en) 2019-01-15

Similar Documents

Publication Publication Date Title
KR100943366B1 (en) Skin cosmetic and wrinkle-reducing agent
US20160317418A1 (en) Method of improving the appearance of skin and compositions therefor
KR102189084B1 (en) A cosmetic composition for improving skin conditions comprising culture fluids of Aureobasidium pullulans
BRPI0812575B1 (en) Use of a Substance, Cosmetic or Dermo-Cosmetic or Neutracutic Composition, Pharmaceutical Composition, Cosmetic Care Method, and Nucleotide Sequence
ES2936724T3 (en) Cosmetic or dermatological composition comprising an extract of Jania rubens and an essential oil of helichrysum and its use
JP2018505130A (en) Method for treating skin conditions and composition therefor
BR112020019983B1 (en) METHODS FOR PROVIDING A SUNSCREEN PRODUCT, SUNSCREEN PRODUCTS AND USE OF A SUNSCREEN PRODUCT
Nordlund et al. The normal color of human skin
ES2959130T3 (en) Moringa peregrina seed cake extract, its obtaining procedure and its use in cosmetic or nutricosmetic compositions
Schoelermann et al. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4‐t‐butylcyclohexanol in patients with rosacea subtype I
CN109700694A (en) A kind of composition and its application with moist moisture-keeping efficacy
BR112016007843B1 (en) NON-THERAPEUTIC COSMETIC USE OF A VIRGINIAN HAMAMELIS EXTRACT, AND, COSMETIC CARE METHOD
CN113041172A (en) Skin lipid membrane bionic composition for skin barrier repair and application thereof and cosmetic
WO2019000067A1 (en) Skin tone-correcting cosmetic composition, use of a cosmetic composition and method for correcting the skin tone in an urban environment
CN106176488B (en) A kind of whitening spot-eliminating composition for adjusting human body inflammatory reaction balance and its application
BR102014025813A2 (en) compositions comprising paulownia tomentosa wood extracts and uses thereof
JP4979126B2 (en) Hair cosmetics
BR112020019812B1 (en) PRODUCTS FOR PROVIDING A CUSTOM COLOR-TINED SUNSCREEN PRODUCT, METHOD FOR PREPARING A CUSTOM-CUSTOM COLOR-TINED SUNSCREEN PRODUCT AND USE OF A PRODUCT
WO2015189630A1 (en) Composition
WO2014028032A1 (en) Topical skin care composition
Gosavi et al. Formulation and evaluation of polyherbal lotus oil
Kaur et al. A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO ASSESS THE VARNYA EFFECT OF RAKTACHANDANADI LEPA AND YAVADI LEPA
CN118319820A (en) Composition with whitening and skin brightening effects and preparation method thereof
BR122024004006A2 (en) MORINGA PEREGRINA SEED PIE EXTRACT, COSMETIC AND NUTRICOSMETICAL COMPOSITIONS AND USE THEREOF
Saputri et al. Phytochemical Screening And Evaluation Of Transparent Soap With Addition Of Wedi Snakefruit (Salacca zalacca) Rind Extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18823695

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18823695

Country of ref document: EP

Kind code of ref document: A1